UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

European heart journal, 2016-09, Vol.37 (33), p.2577-2585

2016

Volltextzugriff (PDF)

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European heart journal, 2022-02, Vol.43 (6), p.474-484

2022

Volltextzugriff (PDF)

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

European heart journal, 2023-06, Vol.44 (21), p.1874-1889

2023

Volltextzugriff (PDF)

Hypertension and the kidney: an update

European heart journal, 2024-05, Vol.45 (17), p.1497-1499

2024

Volltextzugriff (PDF)

Prevention of cardiorenal damage: importance of albuminuria

European heart journal, 2023-04, Vol.44 (13), p.1112-1123

2023

Volltextzugriff (PDF)

Use of chronic kidney disease blind spot to prevent cardiorenal outcomes

European heart journal, 2022-01, Vol.43 (4), p.257-260

2022

Volltextzugriff (PDF)

The year in cardiovascular medicine 2020: epidemiology and prevention

European heart journal, 2021-02, Vol.42 (8), p.813-821

2021

Volltextzugriff (PDF)

Renin–angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs

European heart journal, 2020-06, Vol.41 (22), p.2067-2069

2020

Volltextzugriff (PDF)

Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension

European heart journal, 2017-11, Vol.38 (44), p.3318-3320

2017

Volltextzugriff (PDF)

Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

European heart journal, 2021-10, Vol.42 (40), p.4123-4125

2021

Volltextzugriff (PDF)

High prevalence of masked uncontrolled hypertension in people with treated hypertension

European heart journal, 2014-12, Vol.35 (46), p.3304-3312

2014

Volltextzugriff (PDF)

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology, dialysis, transplantation, 2022-06, Vol.37 (7), p.1261-1269

2022

Volltextzugriff (PDF)

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years

Nephrology, dialysis, transplantation, 2022-01, Vol.37 (2), p.304-310

2022

Volltextzugriff (PDF)

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

Nephrology, dialysis, transplantation, 2023-01, Vol.38 (1), p.10-25

2023

Volltextzugriff (PDF)

The endless story of markers of renal function and cardiovascular risk

European heart journal, 2019-11, Vol.40 (42), p.3494-3495

2019

Volltextzugriff (PDF)

Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes

European heart journal, 2024-06, Vol.45 (31), p.2851

2024

Volltextzugriff (PDF)

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

American journal of hypertension, 2017-05, Vol.30 (5), p.468-469

2017

Volltextzugriff (PDF)

Long-term adherence to therapy: the clue to prevent hypertension consequences

European heart journal, 2013-10, Vol.34 (38), p.2931-2932

Ruilope, Luis M

2013

Volltextzugriff (PDF)

Impact of the new USA and ESC/ESH HTN guidelines for Spain

European heart journal, 2019-06, Vol.40 (21), p.1660-1661

2019

Volltextzugriff (PDF)

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (2), p.372-383

2023

Volltextzugriff (PDF)

Renin-angiotensin system blockade: time for a reappraisal?

European heart journal, 2014-07, Vol.35 (26), p.1703-1705

Ruilope, Luis M

2014

Volltextzugriff (PDF)

Renal function and target organ damage in hypertension

European heart journal, 2011-07, Vol.32 (13), p.1599-1604

2011

Volltextzugriff (PDF)

Was there real denervation in the SYMPLICITY HTN-3 trial?

European heart journal, 2014-07, Vol.35 (26), p.1699-1700

Ruilope, Luis M

2014

Volltextzugriff (PDF)

Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study

European journal of preventive cardiology, 2022-03, Vol.29 (2), p.e50

2022

Volltextzugriff (PDF)

Long-term renal survival in malignant hypertension

Nephrology, dialysis, transplantation, 2010-10, Vol.25 (10), p.3266-3272

2010

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

ThemaBlood Pressure - Drug Effects

KollektionOxford journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(162)

Publikationsform

Artikel
(163)

Sprache

Englisch
(163)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Cardiovascular System & Cardiology
(53)
Humans
(52)
Cardiac & Cardiovascular Systems
(35)
Hypertension
(30)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Risk Factors
(23)
Peripheral Vascular Disease
(20)
Cardiology. Vascular System
(16)
Cardiovascular Risk
(15)
Male
(15)
Arterial Hypertension. Arterial Hypotension
(12)
Blood And Lymphatic Vessels
(12)
Blood Pressure
(12)
Renal Function
(12)
Transplantation
(12)
Urology & Nephrology
(12)
Microalbuminuria
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Hypertension and the kidney: an update

Prevention of cardiorenal damage: importance of albuminuria

Use of chronic kidney disease blind spot to prevent cardiorenal outcomes

The year in cardiovascular medicine 2020: epidemiology and prevention

Renin–angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs

Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension

Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

High prevalence of masked uncontrolled hypertension in people with treated hypertension

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years

Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

The endless story of markers of renal function and cardiovascular risk

Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

Long-term adherence to therapy: the clue to prevent hypertension consequences

Impact of the new USA and ESC/ESH HTN guidelines for Spain

Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study

Renin-angiotensin system blockade: time for a reappraisal?

Renal function and target organ damage in hypertension

Was there real denervation in the SYMPLICITY HTN-3 trial?

Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study

Long-term renal survival in malignant hypertension

Aktive Filter

Suchergebnisse filtern